A very important study was recently published in European Journal of Dermatology. A group of Russian researchers reported the results of the use of Neodymium laser radiation (Nd:YAG 1064 nm) for the treatment of facial carcinoma. They followed the treatment of 2,837 patients with 3,001 histologically confirmed facial skin carcinoma lesions of stages T1-2N0M0: 2,743 primary basal cell carcinomas (BCC), 172 recurrent limited basal cell carcinomas (RLBCC), and 86 primary squamous cells carcinomas (SCC).

Skin cancer is the most common form of all cancers. More than one million new cases of skin cancer are diagnosed in the United States every year. Basal cell carcinoma is the most common and least dangerous form of cancer while melanoma is the least common, but most dangerous.

All patients in the reported study were followed-up from 5 to 11 years (mean: 8.2 years\; median: 7.0 years) after treatment. The overall recurrence rate after treatment with the YAG laser radiation of facial carcinomas was 2.5% of all irradiated tumors. Patients with these various types of face cancer treated by the pulsed YAG laser developed recurrence only in 2.2%-4.6% of cases, which any doctor would agree is an excellent curative result.

Given the scale of the completed study it is clear for any practitioner that Neodymium YAG laser radiation is a safe and effective means of treating facial carcinomas of stages T1-2N0M0 with good cosmetic results.